KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Asset Writedowns and Impairment: 2009-2024

Historic Asset Writedowns and Impairment for Synopsys (SNPS) over the last 16 years, with Oct 2024 value amounting to $19.7 million.

  • Synopsys' Asset Writedowns and Impairment rose 61.80% to $7.6 million in Q3 2025 from the same period last year, while for Jul 2025 it was $28.6 million, marking a year-over-year increase of 25.98%. This contributed to the annual value of $19.7 million for FY2024, which is 1.04% down from last year.
  • Synopsys' Asset Writedowns and Impairment amounted to $19.7 million in FY2024, which was down 1.04% from $19.9 million recorded in FY2023.
  • Synopsys' Asset Writedowns and Impairment's 5-year high stood at $20.9 million during FY2020, with a 5-year trough of -$3.5 million in FY2022.
  • Its 3-year average for Asset Writedowns and Impairment is $12.1 million, with a median of $19.7 million in 2024.
  • Per our database at Business Quant, Synopsys' Asset Writedowns and Impairment slumped by 118.78% in 2022 and then surged by 673.25% in 2023.
  • Yearly analysis of 5 years shows Synopsys' Asset Writedowns and Impairment stood at $20.9 million in 2020, then declined by 11.31% to $18.5 million in 2021, then tumbled by 118.78% to -$3.5 million in 2022, then skyrocketed by 673.25% to $19.9 million in 2023, then dropped by 1.04% to $19.7 million in 2024.